CASE REPORT
Challenges of extensive AIDS-related dry gangrene during COVID-19 pandemic: a case report and mini review
 
More details
Hide details
1
Faculty of Medicine and Pharmacy, Research Centre in the Field of Medical and Pharmaceutical Sciences (ReForm-UDJ), “Dunărea de Jos” University of Galați, Romania
 
2
Department of Infectious Diseases, Infectious Diseases Clinical Hospital, Galati, Romania
 
3
Department of Dermatology, Infectious Diseases Clinical Hospital, Galati, Romania
 
4
Laboratory Department, Infectious Diseases Clinical Hospital, Galati, Romania
 
These authors had equal contribution to this work
 
 
Submission date: 2024-02-16
 
 
Final revision date: 2024-08-26
 
 
Acceptance date: 2024-09-01
 
 
Publication date: 2026-07-01
 
 
Corresponding author
Manuela Arbune   

Department of Clinical Medical, “Dunărea de Jos” University of Galaţi, Romania
 
 
HIV & AIDS Review 2026;25(2):171-175
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The common aetiologias of gangrene are atherosclerosis and diabetes mellitus, while human immunodeficiency virus (HIV) can be one of additional various pathologic conditions. The risk of peripheral arterial disease is higher in HIV-infected population. Almost every pattern and type of vasculitis were described in HIV people, but widespread digital ischemic changes and gangrene of the hands and feet are uncommon presentations.

Case presentation:
We presented a case of a 33-year-old patient from HIV pediatric Romanian cohort, homeless, previous smoker, and drug user. He was diagnosed HIV-positive 28 years ago, and expe­rienced severe opportunistic diseases and multiple failures of antiretroviral treatments. Clinical exami­nation revealed blackish discoloration in both legs and feet, and severe immunosuppression. Debriding, necrotomy, and lavage of the legs were done, and he received directly observed antiretrovirals. The patient was infected with COVID-19. After 24 weeks, the viral load was undetectable, CD4 count increased, and no necrosis observed, but he is totally care-dependent.

Conclusions:
HIV people are vulnerable during COVID-19 pandemic due to the limited access to healthcare and high-risk of COVID-19-associated infections. Gangrene is a rare condition associated with HIV demonstrating poor functional prognosis, even with viral suppression achieved after antiretroviral treatment.
REFERENCES (17)
1.
Al Wahbi A. Operative versus non-operative treatment in diabetic dry toe gangrene. Diabetes Metab Syndr 2019; 13: 959-963.
 
2.
Farber A. Chronic limb-threatening ischemia. N Engl J Med 2018; 379: 171-180.
 
3.
Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med 2017; 377: 2253-2265.
 
4.
Vega LE, Espinoza LR. Human immunodeficiency virus infection (HIV)-associated rheumatic manifestations in thepre- and post-HAART eras. Clin Rheumatol 2020; 39: 2515-2522.
 
5.
Kehler DS, Milic J, Guaraldi G, Fulop T, Falutz J. Frailty in older people living with HIV: current status and clinical management. BMC Geriatr 2022; 22: 919. DOI: 10.1186/s12877-022-03477-7.
 
6.
Kovacs L, Kress TC, Belin de Chantemèle EJ. HIV, combination antiretroviral therapy, and vascular diseases in men and women. JACC Basic Transl Sci 2022; 7: 410-421.
 
7.
Palshikar MG, Palli R, Tyrell A, Maggirwar S, Schifitto G, Singh MV, et al. Executable models of immune signaling pathways in HIV-associated atherosclerosis. NPJ Syst Biol Appl 2022; 8: 35. DOI: 10.1038/s41540-022-00246-5.
 
8.
Rodés B, Cadiñanos J, Esteban-Cantos A, Rodríguez-Centeno J, Arribas JR. Ageing with HIV: challenges and biomarkers. EBio­Medicine 2022; 77: 103896. DOI: 10.1016/j.ebiom.2022.103896.
 
9.
Zhang Q, Peng F, Li M, Yi Q, Tang W, Wu S. Elevated risk of venous thromboembolism in people living with HIV. Viruses 2022; 14: 590. DOI: 10.3390/v14030590.
 
10.
Getawa S, Adane T. Coagulation parameters in human immunodeficiency virus infected patients: a systematic review and meta-analysis. AIDS Res Treat 2022; 2022: 6782595. DOI: 10.1155/2022/6782595.
 
11.
Beckman JA, Duncan MS, Alcorn CW, So-Armah K, Butt AA, Goetz MB, et al. Association of human immunodeficiency virus infection and risk of peripheral artery disease. Circulation 2018; 138: 255-265.
 
12.
Freiberg MS, Duncan MS, Alcorn C, Chang CH, Kundu S, Mumpuni A, et al. HIV Infection and the risk of World Health Organization – defined sudden cardiac death. J Am Heart Assoc 2021; 10: e021268. DOI: 10.1161/JAHA.121.021268.
 
13.
Malladi VSS, Abkari S, Srinivasan VR. Gangrene associated with human immunodeficiency virus (HIV) [Internet]. Gangrene – Current Concepts and Management Options. InTech; 2011. Available at: http://www.intechopen.com/book....
 
14.
Brand M, Woodiwiss AJ, Michel F, Nayler S, Veller MG, Norton GR. Large vessel adventitial vasculitis characterizes patients with critical lower limb ischemia with as compared to without human immunodeficiency virus infection. PLoS One 2014; 9: e106205. DOI: 10.1371/journal.pone.0106205.
 
15.
Vega LE, Espinoza LR. Vasculitides in HIV infection. Curr Rheumatol Rep 2020; 22: 60. DOI: 10.1007/s11926-020-00945-0.
 
16.
Manuel A, Victório T, Gomes C, Martins T, Dias Neto A. Vasculitis: an unusual manifestation in an HIV-infected patient. Braz J Infect Dis 2015; 19: 439-441.
 
17.
Otedo AE, Oyoo GO, Obondi JO, Otieno CF. Vasculitis in HIV: report of eight cases. East Afr Med J 2005; 82: 656-659.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top